Paolini John F. sold KNSA
October 31, 2025 · Form 4 insider transaction
Paolini John F. sold 82,542 shares of Kiniksa Pharmaceuticals International, plc at $37.14 per share, a transaction worth $3.07M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on July 30, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $36.80 and $37.675. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.